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with sub-microscopic parasitaemia and polyclonal
lymphocyte activation outside the endemic
region, in Brazil
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and Cláudio Tadeu Daniel-Ribeiro3,4Abstract
A case of autochthonous Plasmodium vivax malaria with sub-microscopic parasitaemia and polyclonal B-cell activation
(PBA) (as reflected by positive IgM and IgG serology for toxoplasmosis, cytomegalovirus, and antinuclear and rheumatoid
factors) was diagnosed by polymerase chain reaction (PCR) after consecutive negative rapid diagnostic test results and
blood films. The patient, a 44-year-old man from Rio de Janeiro state, Brazil, had visited the Atlantic Forest, a tourist,
non-malaria-endemic area where no autochthonous cases of ’bromeliad malaria‘ has ever been described. The
characteristic pattern of fever, associated with PBA, was the clue to malaria diagnosis, despite consecutive negative
thick blood smears. The study highlights a need for changes in clinical and laboratory diagnostic approaches,
namely the incorporation of PCR as part of the current routine malaria diagnostic methods in non-endemic areas.
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lymphocyte activationBackground
Malaria is a potentially fatal disease, especially for individ-
uals exposed for the first time. The chances of death are
108 times higher if a malaria case is diagnosed and treated
in non-endemic areas, such as Rio de Janeiro [1], than if it
is observed inside the Amazon region, where malaria is
concentrated (99.8% of cases) and health personnel are
more used to and experienced with the disease diagnosis
[2]. The resulting delay in diagnosis is explained not
only by limitations in the management experience of
non-specialists from non-endemic areas, but also by
limited access to experienced microscopists [3].
The non-specificity of clinical presentation of acute
malaria makes it even harder to distinguish from other
febrile conditions on only clinical grounds, before the* Correspondence: patricia.brasil@ipec.fiocruz.br
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reproduction in any medium, provided the orspiking pattern of fever shows up or even if it never
appears. Thus, a travel history is essential in any febrile
patient to evocate malaria diagnosis, mainly in areas of
other endemic infectious diseases, such as dengue in Rio
de Janeiro, where tropical diseases are not prevalent [4].
Although the extra-Amazonian region is considered a
non-endemic area for malaria, autochthonous cases known
as the "bromeliad-malaria" are reported in areas inside
or near the Atlantic Forest, which provides an excellent en-
vironment for Anopheles (Kerteszia) bellator and Anopheles
(Kerteszia) cruzii that can transmit Plasmodium and use
the water collection in bromeliad to their breeding and
larval habitat [5,6]. Autochthonous malaria in the Atlantic
Forest (1,300,000 km2 distributed over 17 states) are
reported mainly in the states of São Paulo [7-10] and
Espírito Santo [11], in the Ribeira Valley and Atlantic
Coast, and are most often due to Plasmodium vivax [7-11].
In the state of Rio de Janeiro, the rare cases of malaria
transmission was restricted, until 2010, to a localized area,
named Lumiar [3,12,13], a district of Nova Friburgo [14]
and a mountainous tourist region, of 700 metres altituded. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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far from Rio de Janeiro [13]. While the state of Sao Paulo
registered 229 autochthonous malaria cases in the period
of 2003 to 2010 [15], the state of Rio de Janeiro reported
29 cases, most of them from Lumiar [14,16].
This case describes the first authochtonous reported case
in a new touristic region, in Mata Atlantica in the state of
Rio de Janeiro and emphasizes the difficulty of malaria diag-
nosis when no history of prior exposure in endemic areas is
associated with consecutive negative rapid diagnostic tests
(RDTs) and negative blood film examinations for the
presence of the parasite, even by an expert team.
Although polymerase chain reaction (PCR) can detect
parasites down to a density of 0.01 parasites per microlitre
and would, therefore, be very useful in sub-microscopic
parasitaemia malaria, it is not usually available in routine
laboratory practice [17] and the diagnosis relies primarily
on light microscopy of blood film, the gold standard for
malaria diagnosis. However, the high degree of suspicion
triggered by the characteristic-spiking pattern of fever
in a 48-hour cycle, in a patient with 16 days of disease,
associated to the practice of routine surveillance of malaria
cases in the Atlantic Forest, prompted the tropical special-
ists to look for a malaria diagnosis by using PCR. During
fever investigation, the incidental laboratory findings
of positive antinuclear factor (ANF) and rheumatoid
factor (RF) testing and serology for toxoplasmosis and
cytomegalovirus IgM and IgG antibodies suggested the
possibility of nonspecific polyclonal B-cell activation
(PBA), substantiating the malaria diagnosis.
Case report
A 44-year-old male engineer from Rio de Janeiro, Brazil,
presented at Instituto de Pesquisa Clínica Evandro Chagas,
Fundação Oswaldo Cruz (IPEC, Fiocruz), with a history of
persistent fever (39°C) for 16 days: initially continuous dur-
ing the first week followed by intermittent high febrile
peaks every 48 hours over the most recent nine days. The
fever was accompanied by severe headache and chills, and
followed by sweating. The man also complained of ab-
dominal pain, nausea, myalgia, and arthralgia. Eleven days
prior to his first consultation at IPEC, the patient had
visited the emergency department of another hospital
for these symptoms and for a single episode of gum
haemorrhage, attributed to dengue fever that was not
confirmed by laboratory tests. Because his symptoms did
not resolve, he visited IPEC for two walk-in consultations
(on days 16 and 18 of the disease).
During the first consultation, the patient reported a
stay at a small farm in Sana, in the Atlantic Forest during
a three-week holiday, 23 days before the onset of fever.
The Atlantic Forest is a commonly visited touristic region
in the Serra do Mar mountain range. The reserve of Sana
is situated at an altitude of 735 m and is 165 km northeastof Rio de Janeiro. The median temperature in the area
ranges from 10°C to 18°C, in the summer and winter,
respectively.
The patient had no co-morbid diseases or any history of
blood transfusion, tissue/organ transplantation, intravenous
drug use, or travel to a malaria-endemic area. He had not
been injured by needle sticks, nor lived or recreated near
ports or airports. Furthermore, he had not experienced
high fevers in the years prior to this event, and he had not
taken drugs with anti-malarial activity either prior to or
after the onset of the disease. During physical examination,
his body temperature was 39°C, his blood pressure was
110/60 mmHg, and his pulse rate was 93 beats per minute.
He appeared pale and had hepatomegaly and abdominal
pain, but neither his spleen nor any of his lymph nodes
were enlarged, and he did not have a cutaneous rash or any
obvious clinical manifestations of bleeding.
A routine laboratory tests diagnosis for fever of undeter-
minated origin was performed: complete blood count,
routine blood chemistry determinations, chest radiograph,
erythrocyte sedimentation rate, antinuclear antibodies,
rheumatoid factor, blood and urine cultures, Cytomegalo-
virus IgM antibodies, heterophile antibody, Human
immunodeficiency virus antibodies, tuberculin skin test,
and, considering the presented fever pattern, blood films,
RTC and PCR were requested to exclude the possibility of
malaria in the individual.
Laboratory test results on admission on the 16th day of
disease were as follows: C-reactive protein, 5 mg/dL;
haemoglobin, 11.9 g/dL; haematocrit, 35%; white blood
cell count, 4,440/L (2,175 neutrophils and 1,864 lympho-
cytes); platelet count, 258,000/mm3; total serum bilirubin,
0.36 mg/dL (direct fraction, 0.11 mg/dL); creatinine,
0.94 mg/dL; alanine aminotransferase (ALT), 45 IU/L;
aspartate aminotransferase (AST), 129 IU/L; serum albumin,
3.8 g/dL; urea, 37 mg/dL; creatinine, 0.94 mg/dL; LDH,
115 UI/L; sodium, 144 mmol/L; potassium, 4.4 mmol/L
and glucose, 91 md/dL.
Routine blood cultures, microscopic urinalysis, and urine
cultures were all negative. Serologic tests for toxoplasmosis
and cytomegalovirus were positive for both IgG and IgM
antibodies. The test results for ANF and RF were also
positive, showing antibody titres of 320 (speckled pattern)
and 64, respectively, whereas the test result for anti-HIV
was negative. Abdominal ultrasound, echocardiography,
and chest radiography results were normal. A microscopic
direct blood examination (thick and thin blood films) was
performed every 48 hours and assessed by two independ-
ent experts (on days 11, 13, and 15 of the disease), and
rapid malaria tests (OptiMal®, on days 16 and 18) repeat-
edly reported negative results. On day 18 of the disease,
single PCR tests for Plasmodium [18] and Plasmodium
vivax [19] were positive, confirming the clinical suspicion
of malaria.
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initiated, and the patient’s fever resolved 24 hours after
the start of treatment. He made a full clinical recovery and
the laboratory abnormalities had normalised by the end of
the treatment. The PCR tested negative for the first time
on the second day and further negative results were
reported on days 7, 21, 28, 40, 60, and 100 after treatment
initiation, confirming that the treatment was curative.
Serologic test results for toxoplasmosis and cytomegalo-
virus were negative on day 100 after the onset of symptoms,
whereas the titres for both RF and ANF were reduced on
the eighth day after treatment.
Consent
Written informed consent to the publication of this case
report was obtained from the patient. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
Discussion
This is the first report of autochthonous, probably
‘bromeliad malaria’ [6] from Atlantic Forest in the
touristic area of Sana, 165 km from the capital, in the
state of Rio de Janeiro, where routine surveillance should
be increased, as cases in the neighbourhood states of São
Paulo and Espírito Santo are occasionnally described [7-11].
The essential clue for the diagnosis of malaria in febrile
patients is an accurate history of malaria exposure in
endemic areas. The patient described here did not visit the
Amazon region, which accounts for 99.8% of registered
malaria cases in Brazil [2], and had not travelled outside
Brazil on any occasion, nor had any previous experience
of epidemiological conditions associated with malaria,
such as transfusional, nosocomial or airport malaria.
Malaria cases from the Atlantic Forest often present with
mild, atypical symptoms and very low levels of parasit-
aemia [9]. Nevertheless, the case reported here presented
headache and classic malarial paroxysms of fever spikes,
chills and rigours at regular intervals, in addition to
hepatomegaly, possibly because of the delay in diagnosis,
after two weeks of disease.
The patient’s long-lasting fever made the diagnosis of
dengue and leptospirosis unlikely, in the same way that
the absence of enlarged lymphonodes or spleen made
infectious mononucleosis and lymphoma improbable.
Other infectious diseases, such as typhoid fever, Q fever,
rickettsial infections, and hepatitis virus, were not consid-
ered or tested for because the resolution of fever after the
institution of specific therapy provided good evidence to
support the presumptive diagnosis of malaria.
General laboratory finds (blood cells count and biochem-
istry) were normal, except for the raised C-reactive levels,
as commonly described in malaria [11]; a slight eleva-
tion of AST, (129 IU/L), and a discrete normocromicand normocytic anaemia (HB = 11.9 g/dL Htc = 35%),
which is attributable, but not specific, to malaria, might be
the result of a long-standing infection. However, in the
fourth week of illness, the patient had no evidence of
haemolysis, as LDH and bilirubin levels were normal. The
absence of thrombocytopaenia, together with normal
glycaemia, might represent the benign aspect of
‘bromeliad-malaria’ with low parasitaemia.
In spite of the negative RDTs and negative parasitaemia
by direct examination of blood smears after consecutive
48-hour intervals, despite no previous treatment, PCR
tests were positive for Plasmodium genera and P. vivax.
Although PCR assays obviously cannot resolve the signifi-
cant problem of lack of clinical suspicion in the diagnosis
of imported malaria [20], it is clinically useful for the diag-
nosis of patient with suspected malaria despite repeated
negative thick-blood-films. The detection of P. vivax DNA
in the peripheral blood, together with the classic clinical
symptoms of malaria, allowed the initiation of anti-malarial
treatment.
The lack of effectiveness of the Optimal® test, which is
considered insufficient at less than 100 parasites/μL, was
not surprising. Commercially-available RDTs do not have
a satisfactory sensitivity in detecting P. vivax, as already
demonstrated by others [21]. A strong caution against the
use of this test alone in health facilities around Rio de
Janeiro is recommended.
The presence of ANF and RF at titres of 320 and 64,
respectively, at the time of diagnosis and the decrease of
these titres after treatment initiation suggest that the
up-regulation of these auto-antibodies could have been
triggered by a state of PBA accompanying the plasmodial
infection. The IgM and IgG antibodies indicating cyto-
megalovirus and toxoplasmosis, which were present at the
time of diagnosis, and the absence of these antibodies after
treatment also support this premise.
Acute and chronic malaria, in both rodent experimental
models [22,23] and natural human disease [24], are, indeed,
usually accompanied by a nonspecific PBA that is reflected
by a marked increase in the concentration of immunoglob-
ulins (IgM and IgG) and the presence of antibodies against
antigens not related to the parasite, including auto-
antigens, in the patient’s serum [25]. PBA most likely
results from a generalised stimulation of T- and B-lym-
phocytes by plasmodial antigens endowed with mitogenic
properties [26], which are released during the course of
infection. For this reason, PBA usually correlates with the
level of ongoing parasitaemia [24], which is in turn associ-
ated with the severity of malaria symptoms. The patient
described here did not have parasitaemia that could be
detected by microscopic examination, which appeared
to contradict the patient’s extensive PBA, likely reflected
by the diversity of the nonspecific immune responses
that were triggered. This finding might indicate that,
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parasite mitogens, other extrinsic and/or individual
(genetic) factors can influence the level of PBA following
parasite stimulation. Studies that investigate the immune
responses to different inocula in animals with different
genetic backgrounds may help to elucidate this concept in
the future.
In addition to malaria, other infectious diseases, such as
African Trypanossomiasis, acute Chagas disease, CMV or
EBV infection and leishmaniosis, are also associated
with PBA and would have to be excluded by appropriate
laboratory tests in other clinical and epidemiological
scenarios.
The genetic characterization of the strain of P. vivax
causing malaria in this case is not in the scope of this
paper and was not explored by the authors. It is, however,
an important issue because unusual P. vivax strains have
been reported in other Atlantic forest cases [7,9]. Further
studies with detailed information regarding the genetic
characteristics of the infecting strain of this and other
cases in different areas the Atlantic Forest are currently
being undertaken.Conclusions
Accurate identification of P. vivax malaria may be a
difficult challenge outside endemic regions and this type
of observation should be primarily reported to clinicians
who are apparently prone to look for possible dengue
fever infection but might be less likely to consider a diag-
nosis of malaria.
Medical practitioners should remain aware of the possi-
bility of malaria in patients presenting fever together with
polyclonal lymphocyte activation detected by multiple
serological positive reactions.
Although expensive and time-consuming, PCR testing
for malaria can be a useful and even exclusive diagnostic
tool in areas with very low or unusual malaria transmission,
where parasitaemia might be undetectable by microscopic
examination. The morbidity of malaria, when misdiagnosed
and mistreated, outweighs drawbacks in the use of PCR
as part of the current routine diagnostic methods in
non-endemic areas.Competing interests
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